MedTrace Logo

Non Invasive Measurement of Coagulation in Term and Preterm Neonates

NCT01167660 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2013-02-12

No results posted yet for this study

Summary

The purpose of this study is to assess the reliability of a new non-invasive device to assess the blood coagulation status among term and preterm babies.

Conditions

  • Blood Coagulation Tests

Interventions

DEVICE

The Thrombo-Monitor (ThM)

Non-invasive measurement of coagulation status and comparison to standard blood coagulation tests. In healthy neonates - immediately after birth, before the administration of vitamin K. Coagulation tests will be done on an umbilical cord blood sample. In sick neonates, coagulation studies will be done according to the medical condition.

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Ita Litmanovitz, MD · Meir Medical Center

Eligibility

Max Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2013-07-31
Completion
2013-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01167660 on ClinicalTrials.gov